Oblique Therapeutics AB (publ.) will be attending to the “BIO International Convention” congress in San Diego from 13-16 June, 2022.

This congress is an opportunity to discuss our R&D activities, and future fundraising goals with an exclusive audience of potential investors and partner.

https://www.bio.org/events/bio-international-convention